Key facts
- This page summarizes Simon May's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Mar 2024, 12:28.
Simon May - 08 Mar 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- EVP, President, LSG
- Issuer ticker
- BIO
- Reported as of
- 08 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2024, 12:28:46 UTC
- Prior SEC filing
- 06 Sep 2023
- Next SEC filing
- 08 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Simon May
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Simon May filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 12 Mar 2024.
Change
- Previous filing in this sequence was filed on 06 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO BIOB
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +3,535
- Change %
- Price
- $0.000000
- Shares after
- 3,535
- Date
- 08 Mar 2024
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 3,535
- Exercise price
- $343.76
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.